Showing results (141-150 of 189) with videos related to

Sort By:
Pageof 19
Cancer Research|March 1, 1994
Alterations of the TP53 gene in human gliomasB K Rasheed, R E McLendon, J E Herndon, et al.
AJNR. American Journal of Neuroradiology|July 1, 1990
MR imaging in patients with temporal lobe seizures: correlation of results with pathologic findingsE R Heinz, B J Crain, R A Radtke, et al.
Journal of Computer Assisted Tomography|September 1, 1991
FDG-PET in the selection of brain lesions for biopsyM W Hanson, M J Glantz, J M Hoffman, et al.
Neurology|November 11, 1991
Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomasM J Glantz, P C Burger, J E Herndon, et al.
Oncogene|June 1, 1995
Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25B K Rasheed, R E McLendon, H S Friedman, et al.
Epilepsia|January 30, 1999
Correlation of hippocampal neuronal density and FDG-PET in mesial temporal lobe epilepsyN Foldvary, N Lee, M W Hanson, et al.
Cancer Chemotherapy and Pharmacology|January 11, 1992
Phase I study of BCNU and intravenous 6-mercaptopurine in patients with anaplastic gliomasD C Smith, N A Vick, D L Trump, et al.
Cancer Research|October 23, 1997
PTEN gene mutations are seen in high-grade but not in low-grade gliomasB K Rasheed, T T Stenzel, R E McLendon, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 1, 1991
Increased AMPA-sensitive quisqualate receptor binding and reduced NMDA receptor binding in epileptic human hippocampusD A Hosford, B J Crain, Z Cao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in ratsA B Heimberger, G E Archer, R E McLendon, et al.
Pageof 19